Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




AI-Enabled Assistant Unifies Molecular Workflow Planning and Support

By LabMedica International staff writers
Posted on 21 May 2026

Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. More...

Fragmented digital tools can slow experiment planning, product selection, and post-purchase support, adding friction to time-sensitive work. A new AI-enabled platform now brings these functions together in a single conversational interface.

QIAGEN (Venlo, Netherlands) has introduced QIA Agent, an AI-powered digital assistant designed to help users plan experiments, identify suitable products, access technical information, and manage ordering through a single interface. The platform can be used with or without logging in, enabling immediate access while offering a more personalized experience for signed-in users, including individual pricing, order history, and account-specific details. QIA Agent builds on QIAGEN’s established digital customer base, which includes more than 260,000 registered “My QIAGEN” users.

QIA Agent functions as a natural-language interface that connects product information, protocols, technical documentation, and support resources to streamline decision-making. It links directly to existing digital services—including the Experiment Configurator, Order Status Checker, Product Availability Checker, and Help Center—creating continuity from experimental design through post-purchase support. Users can check availability, track orders, and retrieve relevant guidance without moving across multiple systems, with the goal of saving time and improving productivity.

The platform is publicly accessible to customers worldwide via QIAGEN’s website. It is currently intended for research use and is not designed for diagnostic applications. By embedding AI-driven guidance into the customer experience, the system aims to reduce time spent searching across disparate tools and to connect users more quickly to relevant information within Sample to Insight workflows.

“Researchers today are navigating growing scientific complexity, increasing volumes of data and expanding workflow choices,” said Nitin Sood, Senior Vice President and Head of Product Portfolio & Innovation at QIAGEN. “QIA Agent is designed to simplify how researchers interact with scientific information, workflow guidance and operational support through a single AI-powered experience. By embedding conversational AI into our digital ecosystem, we aim to help customers move faster from questions to decisions across Sample to Insight workflows.” 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.